Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wasan

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|November 28, 1992
The architecture of cancerJ Waxman, H Wasan
Seminars in Oncology|October 1, 1994
Platinum-based chemotherapy for bladder cancerJ Waxman, H Wasan
The British Journal of Nutrition|February 3, 2000
Functional food properties of non-digestable oligosaccharidesR A Goodlad, H Wasan
European Journal of Cancer (Oxford, England : 1990)|June 26, 2007
An economic evaluation of oxaliplatin for the adjuvant treatment of colon cancer in the United Kingdom (UK)S Aballéa, A Boler, A Craig, et al.
BMJ (Clinical Research Ed.)|March 14, 1992
Myeloma and benign intracranial hypertensionH Wasan, J L Mansi, S Benjamin, et al.
British Journal of Cancer|September 1, 1994
Serum metalloproteinases and their inhibitors: markers for malignant potentialT Baker, S Tickle, H Wasan, et al.
Journal of Medical Economics|May 6, 2015
Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UKB Pennington, R Akehurst, H Wasan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 21, 2017
The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resectionG Poston, R Adam, J Xu, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2020
Immunological combination treatment holds the key to improving survival in pancreatic cancerM H Sodergren, N Mangal, H Wasan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trialsJ W Valle, J Furuse, M Jitlal, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|November 28, 1992
The architecture of cancerJ Waxman, H Wasan
Seminars in Oncology|October 1, 1994
Platinum-based chemotherapy for bladder cancerJ Waxman, H Wasan
The British Journal of Nutrition|February 3, 2000
Functional food properties of non-digestable oligosaccharidesR A Goodlad, H Wasan
European Journal of Cancer (Oxford, England : 1990)|June 26, 2007
An economic evaluation of oxaliplatin for the adjuvant treatment of colon cancer in the United Kingdom (UK)S Aballéa, A Boler, A Craig, et al.
BMJ (Clinical Research Ed.)|March 14, 1992
Myeloma and benign intracranial hypertensionH Wasan, J L Mansi, S Benjamin, et al.
British Journal of Cancer|September 1, 1994
Serum metalloproteinases and their inhibitors: markers for malignant potentialT Baker, S Tickle, H Wasan, et al.
Journal of Medical Economics|May 6, 2015
Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UKB Pennington, R Akehurst, H Wasan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 21, 2017
The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resectionG Poston, R Adam, J Xu, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2020
Immunological combination treatment holds the key to improving survival in pancreatic cancerM H Sodergren, N Mangal, H Wasan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trialsJ W Valle, J Furuse, M Jitlal, et al.
Pageof 4